Tango Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 2 published signal records.
Tango Therapeutics last closed at $23.81 (+5.49%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -28.8×. Its overall grade ranks 110 of 736 stocks in Healthcare.
About this company
Tango Therapeutics last closed at $23.81 (+5.49%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 110/736
Valuation grade A-
Related stocks
- NovartisCustomer
Tango의 표적 항암제 파이프라인은 대형 제약사와의 공동개발·기술이전 가능성이 큰 분야
- MerckCustomer
Tango의 항암 신약 후보는 대형 제약사에 라이선스 아웃될 수 있는 대표적 잠재 파트너
- Bristol Myers SquibbCustomer
면역·항암 포트폴리오를 보유한 빅파마로 Tango의 임상 파이프라인과 사업적으로 연결 가능
ETFs holding this stock
Invesco DWA SmallCap Momentum ETF
Details →About Tango Therapeutics
- What technical signals does Tango Therapeutics (TNGX) have?
- Tango Therapeutics current technical signals: no active technical signal.
- Is Tango Therapeutics a cup-and-handle pattern?
- No. Tango Therapeutics has no valid Cup signal right now.
- What published figures are available for Tango Therapeutics?
- Market cap: $3.2B. Trailing 12 months PER: -28.8×. Latest quarter PBR: 3.48×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about Tango Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.